Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Julphar
Chubb
US Department of Justice
Cipla
Dow
McKinsey
Federal Trade Commission

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021652

« Back to Dashboard

NDA 021652 describes EPZICOM, which is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from six suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the EPZICOM profile page.

The generic ingredient in EPZICOM is abacavir sulfate; lamivudine. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the abacavir sulfate; lamivudine profile page.
Summary for 021652
Tradename:EPZICOM
Applicant:Viiv Hlthcare
Ingredient:abacavir sulfate; lamivudine
Patents:1
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details
Pharmacology for NDA: 021652
Suppliers and Packaging for NDA: 021652
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652 NDA REMEDYREPACK INC. 49349-701 E 49349-701-02
EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652 NDA REMEDYREPACK INC. 49349-701 E 49349-701-19

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 600MG BASE;300MG
Approval Date:Aug 2, 2004TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 14, 2018Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021652

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652-001 Aug 2, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652-001 Aug 2, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652-001 Aug 2, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Viiv Hlthcare EPZICOM abacavir sulfate; lamivudine TABLET;ORAL 021652-001 Aug 2, 2004 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Boehringer Ingelheim
Deloitte
Citi
Federal Trade Commission
Farmers Insurance
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.